Unconfigured Ad

Collapse
X
Collapse
 
  • Page of 1
  • Filter
  • Time
  • Show
Clear All
new posts
Previous template Next
  • cement_head
    Senior Member
    • Mar 2012
    • 264
    #1

    To TESLA or not to TESLA

    Hello,

    I'm in the processing of spec'ing a new bioinformatics workstation for a DNA Genomics Core (academic users) and I have a question on the use of TESLA's for bioinformatics.

    Most of our user base is non-technical and will not be coding/compiling software. They are end-users of produced software, be it FOSS or commercial (e.g. CLC Genomics Workbench, Newbler).

    Is it worth buying a TESLA equipped machine for bioinformatics, or not? We are planning on installing BioLinux 6 (7 when it is ready). If I have interpreted the state-of-affairs right now, GPU enabled software for bioinformatics is not widespread - but is becoming available.

    A second question is: Is it difficult to make software use a GPU/TESLA option? Does the CUDA development kit make this easy, or it actually quite labour/coding intensive at the moment?

    Any thoughts would be welcome.

    Regards,
    Andor
    Tags: biolinux, gpu, tesla
  • ymc
    Senior Member
    • Mar 2010
    • 496
    #2
    For academic beginners, I would recommend trying a GeForce card first, for example, a GTX570, because a Tesla equivalent is about 3x to 5x the price. The development kit is easy to use as long as you know the basics of C and its related development tools in Linux.

    When you find the GTX570 is too slow for double precision math or you think it is not stable enough or you need more VRAM, then move on to the Tesla. For now, it would make sense to wait for the Tesla K20 that comes out end of this year.

    Comment

    • GenoMax
      Senior Member
      • Feb 2008
      • 7142
      #3
      If you are buying this machine mainly for end-users then consider omitting high end GPU and using that money to get additional RAM/SSD's. You would get more out of the machine for normal use that way.

      You can always buy a GPU later and stick it in the machine if you determine that you must have one (or more) down the road.

      Comment

      • arvid
        Senior Member
        • Jul 2011
        • 156
        #4
        I'd agree with GenoMax, if you don't know for sure now that a major software you will be running can use the GPU, use the money for more RAM, cores, SSDs or storage instead.

        Comment

        • adaptivegenome
          Super Moderator
          • Nov 2009
          • 436
          #5
          We are using at GTX480 for development. It is not pricey but we can still develop and run CUDA applications.

          Comment

          Previous template Next

          Latest Articles

          Collapse
          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM
          View All

          ad_right_rmr

          Collapse

          News

          Collapse
          Topics Statistics Last Post
          Chemotherapy Leaves Detectable DNA Signatures in Childhood Tumors by SEQadmin2
          Started by SEQadmin2, Today, 11:41 AM
          0 responses
          8 views
          0 reactions
          		 Last Post SEQadmin2
          by SEQadmin2
          Today, 11:41 AM  
          Single-Cell Atlases Skew Toward European Ancestry, Analysis Finds by SEQadmin2
          Started by SEQadmin2, 07-20-2026, 11:10 AM
          0 responses
          21 views
          0 reactions
          		 Last Post SEQadmin2
          by SEQadmin2
          07-20-2026, 11:10 AM  
          UC San Diego Bioengineers Map Gene Function in Human Stem Cells by SEQadmin2
          Started by SEQadmin2, 07-13-2026, 10:26 AM
          0 responses
          34 views
          0 reactions
          		 Last Post SEQadmin2
          by SEQadmin2
          07-13-2026, 10:26 AM  
          New Analysis Splits Leukemia Into 16 Epigenomic Subgroups by SEQadmin2
          Started by SEQadmin2, 07-09-2026, 10:04 AM
          0 responses
          44 views
          0 reactions
          		 Last Post SEQadmin2
          by SEQadmin2
          07-09-2026, 10:04 AM  
          View All
          Working...